Ligand validation:7OL7

ETF: TRIFLUOROETHANOL

ETF is a Ligand Of Interest in 7OL7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7OL7_ETF_A_207	39%	65%	0.149	0.856	0.47	0.86	-	-	0	0	100%	1
7OL7_ETF_A_208	13%	56%	0.185	0.719	0.95	0.75	-	-	0	0	100%	0.76
1YL1_ETF_X_1940	1%	84%	0.586	0.728	0.32	0.43	-	-	0	0	100%	1
7UCA_ETF_A_404	99%	64%	0.05	0.979	0.72	0.65	-	-	0	0	100%	1
7UA6_ETF_A_404	98%	67%	0.055	0.977	0.85	0.4	-	-	0	0	100%	1
6OWP_ETF_A_404	98%	59%	0.061	0.983	0.48	1.05	-	-	0	0	100%	0.51
7UC9_ETF_A_404	97%	63%	0.057	0.975	0.84	0.57	-	-	0	0	100%	1
4DXH_ETF_A_378	96%	58%	0.058	0.969	0.79	0.82	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.